|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.420 USD | +1.57% |
|
+0.24% | -27.60% |
| 07/07 | RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating | MT |
| 03/07 | CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 66Cr | - | BB | - | - | |||||
| 31TCr | A | ||||||||
| 6.78TCr | AAA | ||||||||
| 922.93Cr | BBB | ||||||||
| 855.86Cr | AA | ||||||||
| 418.16Cr | AAA | ||||||||
| 359.46Cr | - | - | - | ||||||
| 355.05Cr | AA | ||||||||
| 278.82Cr | - | BB | - | - | |||||
| 208.92Cr | - | - | - | - | - | - | - | ||
| 182.65Cr | - | - | - | - | - | ||||
| 175.31Cr | - | - | - | - | - | - | |||
| 164.41Cr | - | - | - | - | - | - | - | ||
| 115.77Cr | - | - | - | - | - | - | - | ||
| 119.5Cr | - | - | - | - | - | - | - | ||
| 108.74Cr | - | BBB | - | - | - | - | - | ||
| 106.33Cr | BBB | ||||||||
| 115.92Cr | - | - | - | - | |||||
| 84Cr | - | - | - | - | - | - | |||
| 88Cr | - | - | - | - | |||||
| Average | 2.15TCr | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- CRMD Stock
- Sector CorMedix Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















